search results for: breakthrough

Neu­ro­crine launch­es CAH rare dis­ease ed­u­ca­tion cam­paign ahead of FDA sub­mis­sion

6 hours ago
Pharma
Marketing

Irish biotech col­lects $75M in Se­ries B to start Phase 3 rare joint tu­mor tri­al

2 days ago
Financing

Cash, chips and tal­ent: In­side Nvidi­a's plan to dom­i­nate biotech's AI rev­o­lu­tion

Last week
R&D
AI

Gink­go, No­vo Nordisk forge ‘flex­i­ble’ re­search pact, from dis­cov­ery to man­u­fac­tur­ing

2 weeks ago
Deals
Manufacturing

Medicxi backs Chi­nese biotech's next-gen KRAS G12C drug with $40M in­jec­tion

3 weeks ago
Financing
China

LENZ ral­lies pres­by­opia aware­ness with eye­care pro­fes­sion­als ahead of FDA sub­mis­sion

3 weeks ago
Pharma
Marketing

Ex­clu­sive: Ex-Re­cur­sion team launch­es Leash Bio, chal­leng­ing AI field with its bet on need­ing more da­ta

3 weeks ago
Financing
AI

Ex­clu­sive: Backed with $350M, se­cre­tive start­up Met­sera jumps in­to the obe­si­ty race

3 weeks ago
Financing
Startups

Ab­b­Vie com­mits to ‘mak­ing the big bets’ in new cor­po­rate cam­paign

4 weeks ago
Pharma
Marketing

Nu­va­tion inks all-stock deal for US-Chi­na on­col­o­gy biotech An­Heart

5 weeks ago
Startups
Deals

Gal­der­ma tar­gets one of this year's biggest Eu­ro­pean IPOs with top-of-the-range share price

Last month
Financing
R&D

Blue­bird's $175M loan; Spyre re­veals sec­ond pri­vate place­ment

Last month
News Briefing

Bris­tol My­ers scores ac­cel­er­at­ed ap­proval in more blood can­cers for CAR-T ther­a­py Breyanzi

Last month
Pharma
Cell/Gene Tx

Bio­gen los­es CMO, neu­ro­mus­cu­lar leader; John Hood adds pres­i­dent, CFO at En­deav­or Bio­Med­i­cines

Last month
People
Peer Review

Takeda's PhII meza­gi­ta­m­ab da­ta; Apogee's $483M raise; Gal­der­ma's IPO

Last month
News Briefing

Eli Lil­ly CEO David Ricks talks Chi­na, AI, and phar­ma's next 'gold­en er­a' af­ter obe­si­ty

Last month
Pharma

Ul­ti­movac­s' melanoma vac­cine fails in PhII; Re­genxbio’s $140M of­fer­ing

Last month
News Briefing

Eli Lil­ly’s Alzheimer’s trek; No­vo Nordisk puts down US roots; Sarep­ta and gene ther­a­py ac­cel­er­at­ed ap­provals; ...

Last month
Weekly
1234 Next page Last page

latest

Most read

Roche un­ruf­fled by Chi­na bill as it looks to grow roots in the re­gion

7 hours ago
China
Manufacturing

Cidara buys back flu rights, sells an­ti­fun­gal and inks $240M PIPE

4 hours ago
Financing
Deals

Fol­low­ing low­er-than-ex­pect­ed prof­its, Evotec plans to cut costs, com­pletes CEO search

5 hours ago
People
Pharma

Sen. Sanders launch­es probe of Novo's We­govy and Ozem­pic pric­ing

5 hours ago
Pharma

Neu­ro­crine launch­es CAH rare dis­ease ed­u­ca­tion cam­paign ahead of FDA sub­mis­sion

6 hours ago
Pharma
Marketing
see latest stream
A service from the Financial Times